The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VANTAVO

70/5600 international unit(s)/millilitre Tablet

Merck Sharp & Dohme LtdEU/1/09/572/6-9

Main Information

Trade NameVANTAVO
Active SubstancesAlendronic acid
Vitamin d3 100.000 iu/g
Strength70/5600 international unit(s)/millilitre
Dosage FormTablet
Licence HolderMerck Sharp & Dohme Ltd
Licence NumberEU/1/09/572/6-9

Group Information

ATC CodeM05BB Bisphosphonates, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued16/10/2009
Legal status*** AWAITING VALUE ***
Supply Status*** AWAITING VALUE ***
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back